Advances in Pharmacoepidemiology and Drug Safety

Advances in Pharmacoepidemiology and Drug Safety
Open Access

ISSN: 2167-1052

Aims and Scope

Index Copernicus Value: 82.47 NLM ID: 101607843

• The journal aims to publish quality articles in pharmacoepidemiology and drug safety which represent the current research trend with a focus on improving public health services and shaping a robust health and drug policy.

• The main focus of the journal is to gather and collate systematic information from diverse sources on all the relevant topics including adverse drug reactions including biochemical changes, impacts on different organs and allergenic reactions; drug regulation; health surveillance; magnitude of risk to benefit ratio of drugs in clinical setup; drug transportation, delivery and therapeutic effect; regulatory aspects of drug safety; economics of drug usage; drug interactions and promotion of public health.

• The Journal intends to provide a clear and rational presentation of expert opinion and views on then-current and emerging challenges in Pharmacoepidemiology and drug safety.

• The journal supports the Bethesda Statement on Open Access Publishing. The articles are published under The Creative Commons User License (CC BY-NC 4.0) which permits third party reuse. The journal constantly strives to raise the visibility and impact of its articles and to provide realistic and diverse knowledge to its reader base.

Relevant Topics